Edesa Biotech is trading 5% down today at $5.09 in a technical pullback following yesterday's rebound, with no fresh company-specific news or filings reported.
- The move appears to be a normal correction following recent volatility, as no new press releases or analyst actions have emerged this morning.
- The decline comes despite broader U.S. markets trading higher, supported by improved sentiment in the tech sector and cooling inflation data.